These novel therapies , Tirzepatide , represent a groundbreaking advancement in managing type 2 diabetes and potentially associated disorders. They are classified as GLP-1 pathway stimulators, https://mayayonw885038.fitnell.com/82522027/tirzepatide-a-thorough-exploration-into-metabolic-copyright